Current Role of Allogeneic Stem Cell Transplantation in Multiple Myeloma.
Oncol Ther
; 10(1): 105-122, 2022 Jun.
Article
in En
| MEDLINE
| ID: mdl-35377068
ABSTRACT
Major progress in the treatment of multiple myeloma has been made in the last several years. However, myeloma remains incurable and patients with high-risk cytogenetics or advanced stage disease have an even worsen survival. Only allogeneic transplantation may have curative potential in some patients. However, the high non-relapse mortality and incidence of chronic graft-versus-host disease have raised controversy regarding this procedure. In this review, we will address the role of upfront and delayed allogeneic transplant.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Oncol Ther
Year:
2022
Document type:
Article
Affiliation country:
Estados Unidos